Enhanced Group Faces $60M Loss After Failed Sports Event

The Enhanced Group, a telehealth company backed by Peter Thiel, suffered a net loss of nearly $62 million in its second-quarter earnings report after hosting the Enhanced Games, a controversial sports event allowing athletes to use performance-enhancing drugs. The games, dubbed the ‘steroid Olympics,’ were hailed as a revolutionary concept but resulted in minimal competitive excitement and commercial failure. While the company’s IPO valued it at $1.2 billion, most of its recent revenue came from sponsorships tied to the event rather than its core telehealth business, which sells FDA-approved treatments like peptides and GLP-1s for weight loss. The report casts doubt on claims that the games would become an annual event, prompting Enhanced to pivot toward a lower-cost online series called Enhanced Breakers. Meanwhile, the broader peptide industry is growing despite regulatory challenges, with government agencies showing interest in deregulation. The article highlights the tension between innovation and ethical concerns in biotech and sports.